Research programme: ghrelin receptor agonist - HelsinnAlternative Names: HM 03; HM03 ghrelin receptor agonist 2
Latest Information Update: 12 Oct 2015
At a glance
- Originator Helsinn
- Mechanism of Action Ghrelin receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Anorexia; Cachexia
Most Recent Events
- 12 Oct 2015 Preclinical trials in Cachexia in Europe (unspecified route)
- 12 Oct 2015 Preclinical trials in Anorexia in Europe (unspecified route)